Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Chemoprevention in Oral Potentially Malignant Lesions
NCT03685409Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Oct 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in Oral potentially malignant disorders (OPMD), sponsored by Cairo University. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Oral potentially malignant disorders (OPMD)
Beyond the preview
Go deeper on NCT03685409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03685409.